Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling
Date
2018-09-01
Author
Soto-Velasquez, Monica
Hayes, Michael P.
Alpsoy, Aktan
Dykhuizen, Emily C.
Watts, Val J.
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
2
views
0
downloads
Cite This
Functional characterization of adenylyl cyclase (AC) isoforms has proven challenging in mammalian cells because of the endogenous expression of multiple AC isoforms and the high background cAMP levels induced by nonselective AC activators. To simplify the characterization of individual transmembrane AC (mAC) isoforms, we generated a human embryonic kidney cell line 293 (HEK293) with low cAMP levels by knocking out two highly expressed ACs, AC3 and AC6, using CRISPR/Cas9 technology. Stable HEK293 cell lines lacking either AC6 (HEK-AC Delta 6) or both AC3 and AC6 (HEK-AC Delta 3/6) were generated. Knockout was confirmed genetically and by comparing cAMP responses of the knockout cells to the parental cell line. HEK-AC Delta 6 and HEK-AC Delta 3/6 cells revealed an 85% and 95% reduction in the forskolin-stimulated cAMP response, respectively. Forskolin- and G alpha(s)-coupled receptor-induced activation was examined for the nine recombinant mAC isoforms in the HEK-AC Delta 3/6 cells. Forskolin-mediated cAMP accumulation for AC1-6 and AC8 revealed 10- to 250-fold increases over the basal cAMP levels. All nine mAC isoforms, except AC8, also exhibited significantly higher cAMP levels than the control cells after G alpha(s)-coupled receptor activation. Isoform-specific AC regulation by protein kinases and Ca2+/calnnodulin was also recapitulated in the knockout cells. Furthermore, the utility of the HEK-AC Delta 3/6 cell line was demonstrated by characterizing the activity of novel AC1 forskolin binding-site mutants. Hence, we have developed a HEK293 cell line deficient of endogenous AC3 and AC6 with low cAMP background levels for studies of cAMP signaling and AC isoform regulation.
URI
https://hdl.handle.net/11511/116678
Journal
MOLECULAR PHARMACOLOGY
DOI
https://doi.org/10.1124/mol.118.111849
Collections
Department of Biology, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
M. Soto-Velasquez, M. P. Hayes, A. Alpsoy, E. C. Dykhuizen, and V. J. Watts, “A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling,”
MOLECULAR PHARMACOLOGY
, vol. 94, no. 3, pp. 963–972, 2018, Accessed: 00, 2025. [Online]. Available: https://hdl.handle.net/11511/116678.